The number of South Koreans infected with Middle East Respiratory Syndrome (MERS) has risen to 15, the health ministry said on Sunday.
Two people in their 30s, who had close contact with a MERS patient being treated in a hospital, were confirmed positive for the deadly viral disease, according to the ministry of health and welfare.
The new cases include a patient who had been hospitalised in the same ward with the patient zero and a visitor to the hospital, according to Xinhua.
The first confirmed case of MERS in South Korea was found in a 68-year-old man who travelled to Bahrain in April and May.
MERS belongs to the same family as the virus that triggered China's 2003 outbreak of Severe Acute Respiratory Syndrome (SARS). Researchers first identified it in 2012, and since then, more than 1,100 cases have been reported in 23 countries.
There is no vaccine to prevent the spread of this deadly virus.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
